Non-small Cell Lung Cancer (NSCLC) Stage III
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer (NSCLC) Stage III
| Record | Firm | Date |
|---|---|---|
| Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer (NCT01731587) | Merck KGaA, Darmstadt, Germany | 2001-01-01 |
Track Non-small Cell Lung Cancer (NSCLC) Stage III automatically
Every clearance here is in the API, with alerts when new ones post.